Glycyrrhizinic acid |
Triterpenoid saponin |
5-Fluorouracil |
Mucoprotective effects, anti-inflammatory, and antioxidant (suppresses inflammatory mediators and oxidative stress via NF-κB and Nrf2 pathways)
Enhances chemosensitivity (nitric oxide regulator)
|
[197,198] |
Cisplatin |
|
[196] |
Cisplatin/radiation |
Enhances chemosensitivity (1. decreases the expression of MRP2, MRP3, MRP4, and MRP5; 2. inhibition of HMGB1)
|
[199,200,201] |
Erlotinib/cisplatin |
|
[202] |
Doxorubicin |
Anti-inflammatory (decreasing phagocytosis of macrophage)
Enhances chemosensitivity (mediates cell apoptosis via Bax/Bcl-2 ratio and caspase-3 activity)
Cardioprotective (inhibition of HMGB1via HMGB1-dependent Akt/mTOR downregulating phospho-Akt, phospho-mTOR, p62, and LC3 II)
|
[204,205,210] |
Paclitaxel |
|
[203,211] |
|
[206] |
N.A. |
|
[212,213] |
Glycyrrhizin |
Cyclosporine (CsA) |
|
[214] |
Isoliquiritigenin |
Trans-chalcone (flavonoid) |
Cisplatin |
Antioxidant effects, and enhances chemosensitivity (enhances ER stress and oxidative stress)
Enhances chemosensitivity (via HO-1 and GRP78/ABCG2)
|
[208,215,216,217] |
Nephro and hepatic protection (increases nitric oxide and tissue lipid peroxidation levels, and depletes GSH levels).
Anti-inflammatory (inhibition of FPR2 in macrophage)
|
[207,218] |
5-Fluorouracil |
|
[219] |
|
|
[220] |
Doxorubicin |
|
[221] |
|
[222,223] |